BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 12050243)

  • 21. The growth hormone response to hexarelin in patients with different hypothalamic-pituitary abnormalities.
    Maghnie M; Spica-Russotto V; Cappa M; Autelli M; Tinelli C; Civolani P; Deghenghi R; Severi F; Loche S
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3886-9. PubMed ID: 9814463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
    Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan.
    Valetto MR; Bellone J; Baffoni C; Savio P; Aimaretti G; Gianotti L; Arvat E; Camanni F; Ghigo E
    Eur J Endocrinol; 1996 Nov; 135(5):568-72. PubMed ID: 8980159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender has to be taken into account in diagnosing adult growth hormone deficiency by the GHRH plus arginine test.
    Markkanen HM; Pekkarinen T; Hämäläinen E; Välimäki MJ; Alfthan H; Stenman UH
    Growth Horm IGF Res; 2017 Aug; 35():52-56. PubMed ID: 28755537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessment of the growth hormone status in young adults with childhood-onset growth hormone deficiency: reappraisal of insulin tolerance testing.
    Secco A; di Iorgi N; Napoli F; Calandra E; Calcagno A; Ghezzi M; Frassinetti C; Fratangeli N; Parodi S; Benassai M; Leitner Y; Gastaldi R; Lorini R; Maghnie M; Radetti G
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4195-204. PubMed ID: 19837937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database.
    Webb SM; Strasburger CJ; Mo D; Hartman ML; Melmed S; Jung H; Blum WF; Attanasio AF;
    J Clin Endocrinol Metab; 2009 Feb; 94(2):392-9. PubMed ID: 19001512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.
    Corneli G; Di Somma C; Baldelli R; Rovere S; Gasco V; Croce CG; Grottoli S; Maccario M; Colao A; Lombardi G; Ghigo E; Camanni F; Aimaretti G
    Eur J Endocrinol; 2005 Aug; 153(2):257-64. PubMed ID: 16061832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency.
    Donaubauer J; Kiess W; Kratzsch J; Nowak T; Steinkamp H; Willgerodt H; Keller E
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):456-63. PubMed ID: 12641629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease.
    Aimaretti G; Corneli G; Di Somma C; Baldelli R; Gasco V; Rovere S; Migliaretti G; Colao A; Tamburrano G; Lombardi G; Ghigo E; Camanni F
    J Endocrinol Invest; 2005 Mar; 28(3):247-52. PubMed ID: 15952410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of arginine plus growth hormone releasing hormone to evaluate growth hormone (GH) secretory status in children with GH deficiency.
    Keller A; Donaubauer J; Kratzsch J; Pfaeffle R; Hirsch W; Kiess W; Keller E
    J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1307-14. PubMed ID: 18341090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
    Maghnie M; Strigazzi C; Tinelli C; Autelli M; Cisternino M; Loche S; Severi F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults.
    Popovic V; Leal A; Micic D; Koppeschaar HP; Torres E; Paramo C; Obradovic S; Dieguez C; Casanueva FF
    Lancet; 2000 Sep; 356(9236):1137-42. PubMed ID: 11030292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children.
    Bellone J; Aimaretti G; Bellone S; Baffoni C; Corneli G; Origlia C; Cappa M; Ghigo E
    J Endocrinol Invest; 2000 Feb; 23(2):97-101. PubMed ID: 10800762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
    Minerva Endocrinol; 1999; 24(3-4):107-11. PubMed ID: 10953725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
    Guzzaloni G; Grugni G; Morabito F
    Minerva Endocrinol; 1998 Dec; 23(4):99-104. PubMed ID: 10361807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GH secretion is impaired in patients with primary hyperparathyroidism.
    Gasperi M; Cecconi E; Grasso L; Bartalena L; Centoni R; Aimaretti G; Broglio F; Miccoli P; Marcocci C; Ghigo E; Martino E
    J Clin Endocrinol Metab; 2002 May; 87(5):1961-4. PubMed ID: 11994325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas.
    Baldelli R; Bianchi A; Diacono F; Passeri M; Fusco A; Valle D; Poggi M; Terlini M; Toscano V; Tamburrano G; Pontecorvi A; Maira G; De Marinis L
    J Endocrinol Invest; 2005 Feb; 28(2):157-61. PubMed ID: 15887862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.